¼¼°èÀÇ MRI ´ëÀÀ ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå
MRI Compatible Pacemaker
»óǰÄÚµå : 1763131
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 196 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,106,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,320,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ MRI ´ëÀÀ ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀº 2030³â±îÁö 29¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 23¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ MRI ´ëÀÀ ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 4.0%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 29¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ºÎÁ¤¸ÆÀº CAGR 4.5%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 15¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿ïÇ÷¼º½ÉºÎÀü ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 3.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 2,240¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 6.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ MRI ´ëÀÀ ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀº 2024³â¿¡ 6¾ï 2,240¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀ» 6.3%·Î 2030³â±îÁö 6¾ï 780¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.4%¿Í 3.2%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ MRI ´ëÀÀ ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

MRI Áö¿ø ½É¹ÚÁ¶À²±â°¡ ½ÉÀå Ä¡·á¿¡ Çõ¸íÀ» °¡Á®¿Ã ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

MRI Áö¿ø ½É¹ÚÁ¶À²±â´Â ±âÁ¸ ½É¹ÚÁ¶À²±â¸¦ »ç¿ëÇϴ ȯÀÚµéÀÌ ¿À·§µ¿¾È °Þ¾î¿Â ¹®Á¦¸¦ ÇØ°áÇÔÀ¸·Î½á ½ÉÀå Ä¡·áÀÇ Áß¿äÇÑ Çõ½ÅÀÌ µÇ°í ÀÖ½À´Ï´Ù. Áö±Ý±îÁö Ç¥ÁØÇü ½É¹ÚÁ¶À²±â¸¦ ÀåÂøÇÑ È¯ÀÚµéÀº ±â±â ¿ÀÀÛµ¿À̳ª °­ÇÑ ÀÚ±âÀå °£¼·ÀÇ À§Çè ¶§¹®¿¡ ÀÚ±â°ø¸í¿µ»ó(MRI) °Ë»ç¸¦ ¾ÈÀüÇÏ°Ô ¹ÞÀ» ¼ö ¾ø¾úÀ¸¸ç, MRI´Â ´Ù¾çÇÑ Áúȯ¿¡ ´ëÇÑ Áß¿äÇÑ Áø´Ü Åø·Î, ƯÈ÷ ½É¹ÚÁ¶À²±â¿Í MRI °Ë»ç¸¦ ¸ðµÎ ÇÊ¿ä·Î ÇÒ °¡´É¼ºÀÌ ³ôÀº °í·ÉÀÇ È¯Àڵ鿡°Ô´Â MRI Áö¿ø ½É¹ÚÁ¶À²±âÀÇ °³¹ßÀº ½É¹ÚÁ¶À²±âÀÇ ±â´ÉÀ» ¼Õ»ó½ÃŰÁö ¾ÊÀ¸¸é¼­µµ ȯÀÚ°¡ ¾ÈÀüÇÏ°Ô Àü½Å MRI °Ë»ç¸¦ ¹ÞÀ» ¼ö ÀÖ´Â Àç·á¿Í ¼³°è¸¦ µµÀÔÇÏ¿© ÀÌ ¹®Á¦¸¦ ÇØ°áÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ½ÉÀ庴 ȯÀÚÀÇ Àå±âÀûÀÎ ÇコÄɾ °³¼±ÇÏ°í »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀº ¾î¶»°Ô MRI Áö¿ø ½É¹ÚÁ¶À²±âÀÇ ±â´ÉÀ» Çâ»ó½Ã۴°¡?

±â¼ú Çõ½ÅÀº MRI Áö¿ø ½É¹ÚÁ¶À²±â °³¹ßÀÇ ÁÖ¿ä ¿øµ¿·ÂÀ̸ç, ÀÌ·¯ÇÑ Àåºñ°¡ ¾ÈÀüÇÑ ¿µ»ó Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ºÎÀÀÇÒ ¼ö ÀÖµµ·Ï º¸ÀåÇÕ´Ï´Ù. Á¦Á¶¾÷üµéÀº MRI ȯ°æ¿¡¼­ÀÇ ³»±¸¼º°ú ¼º´ÉÀ» Çâ»ó½Ã۱â À§ÇØ Ã·´Ü ¼¾¼­, ÇÁ·Î±×·¡¹Ö °¡´ÉÇÑ ±â´É, Çâ»óµÈ ¹èÅ͸® ¼ö¸íÀ» ÀÌ ±â±â¿¡ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä Çõ½ÅÀ¸·Î´Â ƼŸ´½ ¹× ƯÁ¤ Æú¸®¸Ó¿Í °°Àº ºñÀÚ¼º Àç·áÀÇ »ç¿ë°ú MRI ½ºÄµ Áß ¹ß»ýÇÏ´Â ÀÚ±âÀåÀ» °ßµô ¼ö ÀÖµµ·Ï ȸ·Î¸¦ Àç¼³°èÇÏ´Â °Í µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¼±Àº MRI °Ë»ç Áß È¯ÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, ÀϹÝÀûÀÎ ½ÉÀå Ä¡·á¿¡¼­ ½É¹ÚÁ¶À²±âÀÇ Àü¹ÝÀûÀÎ ½Å·Ú¼º°ú ±â´É¿¡µµ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÃֽнɹÚÁ¶À²±âÀÇ ¿ø°Ý ¸ð´ÏÅ͸µ ±â´ÉÀ» ÅëÇØ ÀÇ»ç´Â ȯÀÚÀÇ ½ÉÀå °Ç°­ »óŸ¦ ½Ç½Ã°£À¸·Î ÃßÀûÇÒ ¼ö ÀÖÀ¸¸ç, Áö¼ÓÀûÀÎ ½ÉÀå Ä¡·á¸¦ À§ÇÑ Á¾ÇÕÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

MRI Áö¿ø ½É¹ÚÁ¶À²±âÀÇ Ã¤ÅÃÀ» Çü¼ºÇÏ´Â ±ÔÁ¦ ¹× ½ÃÀå µ¿ÇâÀº?

MRI Áö¿ø ½É¹ÚÁ¶À²±âÀÇ º¸±ÞÀº ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú ÀÇ·á ÀÎÇÁ¶óÀÇ È®´ë¿¡ ÈûÀÔÀº ¹Ù Å®´Ï´Ù. ¹Ì±¹, À¯·´ µî ÁÖ¿ä ½ÃÀå¿¡¼­´Â FDA, À¯·´ÀǾàǰû(European Medicines Agency) µî ±ÔÁ¦±â°üÀÌ MRI Áö¿ø ±â±âÀÇ ½ÂÀÎ ¹× »ç¿ë¿¡ ´ëÇÑ ¸íÈ®ÇÑ °¡À̵å¶óÀÎÀ» ¸¶·ÃÇÏ¿© ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, MRI Áö¿ø ¸ðµ¨À» Á¦°øÇÏ´Â ½É¹ÚÁ¶À²±â Á¦Á¶¾÷üÀÇ ¼ö°¡ Áõ°¡Çϸ鼭 °æÀïÀÌ Ä¡¿­ÇØÁ³°í, ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎ¿¡°Ô º¸´Ù ÇÕ¸®ÀûÀÎ °¡°ÝÀÇ ¼±ÅñÇÀ» Á¦°øÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¾Æ½Ã¾Æ¿Í ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ½ÅÈï °æÁ¦±Ç¿¡¼­µµ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»óÀ¸·Î ÀÎÇØ ½É¹ÚÁ¶À²±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² Àα¸ º¯È­, ƯÈ÷ Àü ¼¼°è °í·ÉÈ­ Ãß¼¼´Â MRI Áö¿ø ½É¹ÚÁ¶À²±â¸¦ Æ÷ÇÔÇÑ ½ÉÀå °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

MRI Áö¿ø ½É¹ÚÁ¶À²±â ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµË´Ï´Ù.

MRI Áö¿ø ½É¹ÚÁ¶À²±â ½ÃÀåÀÇ ¼ºÀåÀº ƯÈ÷ ½É¹ÚÁ¶À²±â ÀÌ½Ä ¹× ÀæÀº ¿µ»ó Áø´ÜÀÌ ÇÊ¿äÇÑ °í·ÉÃþ¿¡¼­ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡ µî ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ³»±¸¼ºÀÌ ¶Ù¾î³ª°í, ÇÁ·Î±×·¡¹ÖÀÌ °¡´ÉÇϸç, ¼ÒÇüÈ­µÈ ±â±âÀÇ °³¹ß µî ±â¼ú ¹ßÀüµµ äÅ÷üÀ» ³ôÀÌ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¾ÇÕÀûÀÎ Áø´Ü Ä¡·á¿¡¼­ MRI ÀûÇÕ¼ºÀÇ Á߿伺¿¡ ´ëÇÑ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ·¯ÇÑ ÀåºñÀÇ ±ÇÀå·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º¸´Ù ¾ÈÀüÇϰí È¿°úÀûÀÎ Àå±âÀûÀÎ ½ÉÀå ¼Ö·ç¼Ç¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ¼±È£´Â ¼±Áø±¹°ú ½ÅÈï °æÁ¦±¹ÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ÇÔ²² ½ÃÀå¿¡ ´õ¿í Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú ÀÇ·á ÀÎÇÁ¶óÀÇ È®´ë´Â MRI Áö¿ø ½É¹ÚÁ¶À²±â¿¡ ´ëÇÑ Á¢±ÙÀ» ¿ëÀÌÇÏ°Ô Çϰí, ¼¼°è ½ÃÀå¿¡¼­ ´õ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

¿ëµµ(ºÎÁ¤¸Æ, ¿ïÇ÷¼º½ÉºÎÀü, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø¡¤½ÉÀå ¼¾ÅÍ, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global MRI Compatible Pacemaker Market to Reach US$2.9 Billion by 2030

The global market for MRI Compatible Pacemaker estimated at US$2.3 Billion in the year 2024, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Arrhythmias, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Congestive Heart Failure segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$622.4 Million While China is Forecast to Grow at 6.3% CAGR

The MRI Compatible Pacemaker market in the U.S. is estimated at US$622.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$607.8 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global MRI Compatible Pacemaker Market - Key Trends & Drivers Summarized

Why Are MRI Compatible Pacemakers Revolutionizing Cardiac Care?

MRI compatible pacemakers have become a crucial innovation in cardiac care, addressing a long-standing challenge faced by patients with traditional pacemakers. Historically, patients with standard pacemakers could not safely undergo magnetic resonance imaging (MRI) scans due to the risk of device malfunction or interference caused by the powerful magnetic fields. This posed a significant limitation, as MRIs are a critical diagnostic tool for various conditions, particularly for elderly patients who are more likely to require both pacemakers and MRI scans. The development of MRI compatible pacemakers has resolved this issue by incorporating materials and designs that allow patients to safely undergo full-body MRIs without compromising the pacemaker’s functionality. This advancement is enabling better long-term health management for cardiac patients and improving their quality of life.

How Is Technology Enhancing the Functionality of MRI Compatible Pacemakers?

Technological innovation is a key driver in the development of MRI compatible pacemakers, ensuring that these devices meet the growing demand for safe diagnostic imaging. Manufacturers are integrating advanced sensors, programmable features, and enhanced battery life into these devices to improve both their durability and performance in MRI environments. Key innovations include the use of non-magnetic materials, such as titanium and specific polymers, and the redesign of circuitry that can withstand the magnetic fields generated during MRI scans. These improvements not only enhance patient safety during MRI procedures but also contribute to the overall reliability and functionality of pacemakers in regular cardiac therapy. Additionally, remote monitoring capabilities in modern pacemakers allow physicians to track the patient’s heart health in real-time, providing a comprehensive solution for continuous cardiac care.

What Are the Regulatory and Market Trends Shaping the Adoption of MRI Compatible Pacemakers?

The growing adoption of MRI compatible pacemakers is being supported by favorable regulatory approvals and expanding healthcare infrastructure. In key markets like the United States and Europe, regulatory bodies such as the FDA and the European Medicines Agency have established clear guidelines for the approval and use of MRI compatible devices, ensuring their safety and effectiveness. As a result, the number of pacemaker manufacturers offering MRI compatible models is rising, creating increased competition and more affordable options for healthcare providers and patients alike. Emerging economies in Asia and Latin America are also experiencing increased demand for these devices due to the rising prevalence of cardiovascular diseases and improving access to advanced healthcare technologies. In parallel, demographic trends, particularly the aging global population, are further fueling the demand for cardiac care solutions, including MRI compatible pacemakers.

The Growth in the MRI Compatible Pacemaker Market Is Driven by Several Factors

The growth in the MRI compatible pacemaker market is driven by several factors, including the increasing prevalence of cardiovascular diseases, especially among aging populations who are more likely to require pacemaker implants and frequent diagnostic imaging. Technological advancements, such as the development of more durable, programmable, and miniaturized devices, are also boosting adoption rates. Additionally, rising awareness among healthcare providers about the importance of MRI compatibility for comprehensive diagnostic care is leading to higher recommendations for these devices. Patient preferences for safer and more effective long-term cardiac solutions are further influencing the market, along with growing healthcare expenditure in both developed and emerging economies. Finally, regulatory support and the expansion of healthcare infrastructure are facilitating easier access to MRI compatible pacemakers, making them more widely available across global markets.

SCOPE OF STUDY:

The report analyzes the MRI Compatible Pacemaker market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Arrhythmias, Congestive Heart Failure, Other Applications); End-Use (Hospitals & Cardiac Centers, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â